Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics - Oligonucleotide Therapeutics Society

Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics

AUTHOR

OTS

DATE

April 30, 2018

CATEGORIES

SHARE

Post Views: 304

Urbanski LM, Leclair N, Anczuków O.
Wiley Interdiscip Rev RNA. 2018 Apr 25:e1476.

Related articles

Subscribe to our Newsletter

OTS_Logo_retina

Oligonucleotide Therapeutics Society

c/o Event Innovations, Inc.
4377 Newport Avenue
San Diego, CA 92107, USA

(619) 795-9458
info@oligotherapeutics.org

Resources

Stay Connected

Search

Subscribe in a reader

© Copyright 2012 – 2022 | Oligotherapeutics.org | All Rights Reserved | Finfrock Marketing

Username/Email Address:
Password:
Forgot Password? | Sign Up

Save Password

First Name *
Last Name *
Username *
Email *
Password *
Confirm Password *
Phone:
Organization Name
Select Sectors
By clicking checkbox, you agree to our Terms and Conditions and Privacy Policy

Already have an account? Login